Medical presentation of constipation from childhood to early adulthood: a population-based cohort study

Denesh K Chitkara1, Nicholas J Talley, G Richard Locke

  • 1University of North Carolina Center for Functional GI and Motility Disorders, Division of Pediatric Gastroenterology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

Insights

Early constipation diagnosis and being female increase the risk for future constipation issues in children and adults. This study tracked a birth cohort to understand these lifelong patterns.

Area of Science:

  • Pediatric Gastroenterology
  • Epidemiology
  • Public Health

Background:

  • Constipation is a prevalent condition affecting both children and adults.
  • The influence of gender and early life factors on constipation development is not well understood.

Purpose of the Study:

  • To determine the incidence of medical visits for constipation in a population-based birth cohort.
  • To identify risk factors, including gender and early life events, associated with constipation from childhood to adulthood.

Main Methods:

  • Utilized a birth cohort of children born between 1976-1982 in Rochester, Minnesota.
  • Identified constipation cases through diagnosis codes and medical chart reviews.
  • Followed subjects up to age 21, with 80% remaining in the community until age 18.

Main Results:

  • Overall incidence of constipation presentation was 3.9 per 1000 person-years.
  • Females showed a higher incidence of constipation starting at age 13 (RR 2.6-4.2).
  • Children with constipation before age 5 had significantly higher rates of later medical visits (RR 2.5-4.5).

Conclusions:

  • Early medical diagnosis of constipation is a key predictor of future visits.
  • Female sex is associated with an increased incidence of constipation into early adulthood.
  • These findings highlight the importance of early intervention and sex-specific considerations for constipation management.
Abstract

Related Concept Videos

Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Diverticular Disease of the Colon01:27

Diverticular Disease of the Colon

Diverticular disease involves the formation of diverticula—small sac-like outpouchings of the colonic wall—and their complications. It most commonly affects the sigmoid colon due to higher intraluminal pressure and structural vulnerability. It results from structural weakness and increased pressure in the colon, producing pseudodiverticula that may remain silent or progress to inflammation and serious complications.Structure of DiverticulaIn diverticulosis, these outpouchings are...